A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9 (Q56532851)
Jump to navigation
Jump to search
article
Language | Label | Description | Also known as |
---|---|---|---|
English | A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9 |
article |
Statements
A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003 (English)
A S Garden
K K Fu
T F Pajak
A Trotti
C U Jones
S A Spencer
T L Phillips
J A Ridge
1 August 2000